Suwon, South Korea

Wonbeom Park

This inventor holds 1 USPTO granted patent. Top assignee: Mvrix Co., Ltd.. Active years: 2024.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Wonbeom Park

Introduction

Wonbeom Park is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibacterial compositions. His work focuses on utilizing protein complexes to enhance antibacterial effects, which can have important applications in medicine.

Latest Patents

Wonbeom Park holds a patent for a "Protein complex including botulinum toxin translocation domain and endolysin and antibacterial composition including same." This innovative protein complex incorporates a botulinum toxin translocation domain and endolysin, demonstrating an effective antibacterial effect. The invention can be utilized as an antibacterial composition or an antibiotic, showcasing its potential in combating bacterial infections.

Career Highlights

Park is associated with Mvrix Co., Ltd., where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative solutions in the field of health and medicine. With a focus on practical applications, he aims to contribute to the improvement of public health through his inventions.

Collaborations

Some of his notable coworkers include Jihwan Chun and Dae Hyuk Kweon. Their collaboration enhances the research environment and fosters innovation within the company.

Conclusion

Wonbeom Park's contributions to the field of biotechnology through his innovative patent highlight the importance of research in developing effective antibacterial solutions. His work exemplifies the potential of scientific advancements to improve health outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…